TRiCares SAS: Valuation, Funding & Investors
TRiCares is a privately held medical device company developing Topaz, a minimally invasive transcatheter tricuspid valve replacement (TTVR) system designed to eliminate tricuspid regurgitation. The company focuses on transfemoral and transjugular delivery methods, advancing clinical studies in Europe and the US to progress toward regulatory approvals.
Leadership & Board
- Current Number of Employees
- 68
- Current LinkedIn Followers
- 3,427
Latest Estimated Valuation
- Total Amount Raised
- $20M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $20M
- Latest Funding Round
- Investment
Company Momentum
PositiveTRiCares SAS LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
TRiCares SAS had 68 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
TRiCares SAS had 3,427 followers as of November 9, 2026. The number of followers increased by 32 (0.94%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 20, 2026 | Investment | $20.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| European Investment Bank | Investment |
Similar Companies
A snapshot of private companies similar to TRiCares SAS, helping you discover and navigate related company profiles.
